BCIQ Deal Charts: First Half 2014 Highlights shows the year off to a strong start, with key details on global pharmaceutical sector M&A, partnerships and top areas of activity.
Get an overview of the pharmaceutical sector merger and acquisition deals that took place in the first six months of 2014. BCIQ Deal Charts: First Half 2014 Highlights includes a series of charts, developed by BioCentury Publications in association with Merrill Corporation, highlighting valuable data and observations. It calls out, for instance, how average product and technology deal size more than doubled over 2013 and which disease area saw as many deals in the first half of 2014 compared to all of 2013.
- M&A deals in 2014 compared to 2013, broken down by company size and disease category
- Partnerships in 2014 compared to 2013, broken down by product and technology, stages at signing and disease category
- Details on some of the largest deals, including the $2.1 billion partnership deal between Bayer and Merck & Co.